nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Cranial nerve paralysis—Vincristine—colon cancer	0.174	0.174	CcSEcCtD
Nalidixic Acid—Cranial nerve paralysis—Methotrexate—colon cancer	0.0842	0.0842	CcSEcCtD
Nalidixic Acid—Joint stiffness—Capecitabine—colon cancer	0.0432	0.0432	CcSEcCtD
Nalidixic Acid—Blister—Fluorouracil—colon cancer	0.0259	0.0259	CcSEcCtD
Nalidixic Acid—Blister—Capecitabine—colon cancer	0.0181	0.0181	CcSEcCtD
Nalidixic Acid—Injury—Irinotecan—colon cancer	0.0154	0.0154	CcSEcCtD
Nalidixic Acid—Swelling—Fluorouracil—colon cancer	0.0154	0.0154	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Irinotecan—colon cancer	0.0146	0.0146	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Fluorouracil—colon cancer	0.0142	0.0142	CcSEcCtD
Nalidixic Acid—Eosinophilia—Fluorouracil—colon cancer	0.0116	0.0116	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Vincristine—colon cancer	0.0115	0.0115	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Vincristine—colon cancer	0.011	0.011	CcSEcCtD
Nalidixic Acid—Swelling—Capecitabine—colon cancer	0.0107	0.0107	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Fluorouracil—colon cancer	0.0107	0.0107	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Capecitabine—colon cancer	0.0105	0.0105	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Fluorouracil—colon cancer	0.0102	0.0102	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Capecitabine—colon cancer	0.0099	0.0099	CcSEcCtD
Nalidixic Acid—Diplopia—Capecitabine—colon cancer	0.00947	0.00947	CcSEcCtD
Nalidixic Acid—Visual impairment—Irinotecan—colon cancer	0.00943	0.00943	CcSEcCtD
Nalidixic Acid—Erythema—Fluorouracil—colon cancer	0.00816	0.00816	CcSEcCtD
Nalidixic Acid—Vertigo—Vincristine—colon cancer	0.00786	0.00786	CcSEcCtD
Nalidixic Acid—Leukopenia—Vincristine—colon cancer	0.00783	0.00783	CcSEcCtD
Nalidixic Acid—Vertigo—Irinotecan—colon cancer	0.00765	0.00765	CcSEcCtD
Nalidixic Acid—Leukopenia—Irinotecan—colon cancer	0.00762	0.00762	CcSEcCtD
Nalidixic Acid—Convulsion—Vincristine—colon cancer	0.00758	0.00758	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Capecitabine—colon cancer	0.00747	0.00747	CcSEcCtD
Nalidixic Acid—Leukopenia—Fluorouracil—colon cancer	0.0073	0.0073	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—colon cancer	0.00728	0.00728	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00723	0.00723	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Capecitabine—colon cancer	0.00715	0.00715	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Vincristine—colon cancer	0.00714	0.00714	CcSEcCtD
Nalidixic Acid—Convulsion—Fluorouracil—colon cancer	0.00707	0.00707	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vincristine—colon cancer	0.00699	0.00699	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Irinotecan—colon cancer	0.00695	0.00695	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Irinotecan—colon cancer	0.00681	0.00681	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Fluorouracil—colon cancer	0.00666	0.00666	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Fluorouracil—colon cancer	0.00652	0.00652	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Vincristine—colon cancer	0.0065	0.0065	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vincristine—colon cancer	0.00641	0.00641	CcSEcCtD
Nalidixic Acid—Visual impairment—Capecitabine—colon cancer	0.00631	0.00631	CcSEcCtD
Nalidixic Acid—Paraesthesia—Irinotecan—colon cancer	0.00624	0.00624	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Capecitabine—colon cancer	0.00619	0.00619	CcSEcCtD
Nalidixic Acid—Somnolence—Irinotecan—colon cancer	0.00618	0.00618	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00607	0.00607	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—colon cancer	0.00603	0.00603	CcSEcCtD
Nalidixic Acid—Paraesthesia—Fluorouracil—colon cancer	0.00598	0.00598	CcSEcCtD
Nalidixic Acid—Somnolence—Fluorouracil—colon cancer	0.00592	0.00592	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vincristine—colon cancer	0.00584	0.00584	CcSEcCtD
Nalidixic Acid—Erythema—Capecitabine—colon cancer	0.0057	0.0057	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Irinotecan—colon cancer	0.00568	0.00568	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vincristine—colon cancer	0.00564	0.00564	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—colon cancer	0.00556	0.00556	CcSEcCtD
Nalidixic Acid—Abdominal pain—Irinotecan—colon cancer	0.0055	0.0055	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—colon cancer	0.00543	0.00543	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00538	0.00538	CcSEcCtD
Nalidixic Acid—Urticaria—Fluorouracil—colon cancer	0.00529	0.00529	CcSEcCtD
Nalidixic Acid—Vertigo—Capecitabine—colon cancer	0.00512	0.00512	CcSEcCtD
Nalidixic Acid—Asthenia—Vincristine—colon cancer	0.00512	0.00512	CcSEcCtD
Nalidixic Acid—Leukopenia—Capecitabine—colon cancer	0.0051	0.0051	CcSEcCtD
Nalidixic Acid—Asthenia—Irinotecan—colon cancer	0.00499	0.00499	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vincristine—colon cancer	0.00488	0.00488	CcSEcCtD
Nalidixic Acid—Arthralgia—Capecitabine—colon cancer	0.00485	0.00485	CcSEcCtD
Nalidixic Acid—Diarrhoea—Irinotecan—colon cancer	0.00476	0.00476	CcSEcCtD
Nalidixic Acid—Dizziness—Vincristine—colon cancer	0.00472	0.00472	CcSEcCtD
Nalidixic Acid—Pruritus—Fluorouracil—colon cancer	0.00471	0.00471	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—colon cancer	0.0047	0.0047	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—colon cancer	0.00461	0.00461	CcSEcCtD
Nalidixic Acid—Dizziness—Irinotecan—colon cancer	0.0046	0.0046	CcSEcCtD
Nalidixic Acid—Diarrhoea—Fluorouracil—colon cancer	0.00456	0.00456	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Capecitabine—colon cancer	0.00456	0.00456	CcSEcCtD
Nalidixic Acid—Vomiting—Vincristine—colon cancer	0.00454	0.00454	CcSEcCtD
Nalidixic Acid—Rash—Vincristine—colon cancer	0.0045	0.0045	CcSEcCtD
Nalidixic Acid—Dermatitis—Vincristine—colon cancer	0.0045	0.0045	CcSEcCtD
Nalidixic Acid—Headache—Vincristine—colon cancer	0.00447	0.00447	CcSEcCtD
Nalidixic Acid—Vomiting—Irinotecan—colon cancer	0.00442	0.00442	CcSEcCtD
Nalidixic Acid—Dizziness—Fluorouracil—colon cancer	0.0044	0.0044	CcSEcCtD
Nalidixic Acid—Rash—Irinotecan—colon cancer	0.00438	0.00438	CcSEcCtD
Nalidixic Acid—Dermatitis—Irinotecan—colon cancer	0.00438	0.00438	CcSEcCtD
Nalidixic Acid—Headache—Irinotecan—colon cancer	0.00435	0.00435	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—colon cancer	0.00424	0.00424	CcSEcCtD
Nalidixic Acid—Nausea—Vincristine—colon cancer	0.00424	0.00424	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00424	0.00424	CcSEcCtD
Nalidixic Acid—Vomiting—Fluorouracil—colon cancer	0.00423	0.00423	CcSEcCtD
Nalidixic Acid—Rash—Fluorouracil—colon cancer	0.0042	0.0042	CcSEcCtD
Nalidixic Acid—Dermatitis—Fluorouracil—colon cancer	0.00419	0.00419	CcSEcCtD
Nalidixic Acid—Paraesthesia—Capecitabine—colon cancer	0.00418	0.00418	CcSEcCtD
Nalidixic Acid—Headache—Fluorouracil—colon cancer	0.00417	0.00417	CcSEcCtD
Nalidixic Acid—Nausea—Irinotecan—colon cancer	0.00413	0.00413	CcSEcCtD
Nalidixic Acid—Nausea—Fluorouracil—colon cancer	0.00395	0.00395	CcSEcCtD
Nalidixic Acid—Vertigo—Methotrexate—colon cancer	0.00381	0.00381	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Capecitabine—colon cancer	0.0038	0.0038	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—colon cancer	0.0038	0.0038	CcSEcCtD
Nalidixic Acid—Urticaria—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Nalidixic Acid—Abdominal pain—Capecitabine—colon cancer	0.00368	0.00368	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—colon cancer	0.00368	0.00368	CcSEcCtD
Nalidixic Acid—Arthralgia—Methotrexate—colon cancer	0.00361	0.00361	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—colon cancer	0.00346	0.00346	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—colon cancer	0.00339	0.00339	CcSEcCtD
Nalidixic Acid—Asthenia—Capecitabine—colon cancer	0.00334	0.00334	CcSEcCtD
Nalidixic Acid—Pruritus—Capecitabine—colon cancer	0.00329	0.00329	CcSEcCtD
Nalidixic Acid—Diarrhoea—Capecitabine—colon cancer	0.00318	0.00318	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00316	0.00316	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—colon cancer	0.00311	0.00311	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—colon cancer	0.00308	0.00308	CcSEcCtD
Nalidixic Acid—Dizziness—Capecitabine—colon cancer	0.00308	0.00308	CcSEcCtD
Nalidixic Acid—Vomiting—Capecitabine—colon cancer	0.00296	0.00296	CcSEcCtD
Nalidixic Acid—Rash—Capecitabine—colon cancer	0.00293	0.00293	CcSEcCtD
Nalidixic Acid—Dermatitis—Capecitabine—colon cancer	0.00293	0.00293	CcSEcCtD
Nalidixic Acid—Headache—Capecitabine—colon cancer	0.00291	0.00291	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—colon cancer	0.00283	0.00283	CcSEcCtD
Nalidixic Acid—Nausea—Capecitabine—colon cancer	0.00276	0.00276	CcSEcCtD
Nalidixic Acid—Urticaria—Methotrexate—colon cancer	0.00275	0.00275	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—colon cancer	0.00274	0.00274	CcSEcCtD
Nalidixic Acid—Asthenia—Methotrexate—colon cancer	0.00249	0.00249	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—colon cancer	0.00245	0.00245	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Nalidixic Acid—Dizziness—Methotrexate—colon cancer	0.00229	0.00229	CcSEcCtD
Nalidixic Acid—Vomiting—Methotrexate—colon cancer	0.0022	0.0022	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—colon cancer	0.00218	0.00218	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—colon cancer	0.00218	0.00218	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—colon cancer	0.00217	0.00217	CcSEcCtD
Nalidixic Acid—Nausea—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
